In other words, CaM variants associated with LQTS and CPVT must recognize RyR channels in skeletal (RyR1) and cardiac (RyR2) muscle cells differently from WT CaM. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.